nach oben

Rheumatology International

Erschienen in:

01.03.2013 | Review

Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review

verfasst von: Giorgio Treglia, Maria Vittoria Mattoli, Francesco Bertagna, Raffaele Giubbini, Alessandro Giordano

Erschienen in: Rheumatology International | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

To systematically review the literature data on the role of Fluorine-18-fluorodeoxyglucose positron emission tomography and positron emission tomography/computed tomography (FDG-PET and PET/CT) in patients with retroperitoneal fibrosis (RF), PubMed/MEDLINE, Embase and Scopus databases were searched for articles that evaluated the usefulness of FDG-PET and PET/CT in patients with RF from inception to March 31, 2012. Review articles or editorials, articles not in the field of interest of this review, case reports and preclinical studies were excluded. Only studies including FDG-PET or PET/CT scans performed in at least three patients with RF were included. Ten studies comprising a total of 101 patients with RF were found. The main findings of the included studies are described. FDG-PET and PET/CT are feasible and suitable imaging methods for evaluating patients with RF. These functional imaging techniques seem to be useful both in the diagnosis (mainly in the assessment of activity and extent of the disease) and in evaluating the treatment response in patients with RF. Given the heterogeneity among the various studies for PET analysis and diagnostic criteria, a standardization of the technique is required in order to achieve reproducible and inter-observer independent results. Moreover, further studies are needed to substantiate the role of FDG-PET and PET/CT in patients with RF.

Vaglio A, Salvarani C, Buzio C (2006) Retroperitoneal fibrosis. Lancet 367:241–251CrossRefPubMed

Gilkeson GS, Allen NB (1996) Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin N Am 22:23–38CrossRef

Haug ES, Skomsvoll JF, Jacobsen G, Halvorsen TB, Saether OD, Myrhe HO (2003) Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. J Vasc Surg 38:492–497CrossRefPubMed

Pipitone N, Salvarani C, Peter HH (2010) Chronic periaortitis. Internist 51:45–52CrossRefPubMed

Palmisano A, Vaglio A (2009) Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol 23:339–353CrossRefPubMed

Hughes D, Buckley PJ (1993) Idiopathic retroperitoneal fibrosis is a macrophage-rich process. Implications for its pathogenesis and treatment. Am J Surg Pathol 17:482–490CrossRefPubMed

Vaglio A, Greco P, Corradi D, Palmisano A, Martorana D, Ronda N, Buzio C (2006) Autoimmune aspects of chronic periaortitis. Autoimmun Rev 5:458–464CrossRefPubMed

Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C (2003) Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 114:454–462CrossRefPubMed

Littlejohn GO, Keystone EC (1981) The association of retroperitoneal fibrosis with systemic vasculitis and HLA-B27: a case report and review of the literature. J Rheumatol 8:665–669PubMed

10.

Okada H, Takahira S, Sugahara S, Nakamoto H, Suzuki H (1999) Retroperitoneal fibrosis and systemic lupus erythematosus. Nephrol Dial Transplant 14:1300–1302CrossRefPubMed

11.

Moroni G, Faricciotti A, Cappelletti M, Ponticelli C (1999) Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents. Nephrol Dial Transplant 14:1303–1305CrossRefPubMed

12.

Brandt AS, Kamper L, Kukuk S, Haage P, Roth S (2011) Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry. J Urol 185:526–531CrossRefPubMed

13.

Vaglio A (2009) Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis. Medicine (Baltimore) 88:208–210CrossRef

14.

Vivas I, Nicolás AI, Velázquez P, Elduayen B, Fernández-Villa T, Martínez-Cuesta A (2000) Retroperitoneal fibrosis: typical and atypical manifestations. Br J Radiol 73:214–222PubMed

15.

Cronin CG, Lohan DG, Blake MA, Roche C, McCarthy P, Murphy JM (2008) Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol 191:423–431CrossRefPubMed

16.

Treglia G, Cason E, Fagioli G (2010) Recent applications of nuclear medicine in diagnostics—first part. Ital J Med 4:84–91CrossRef

17.

Treglia G, Cason E, Fagioli G (2010) Recent applications of nuclear medicine in diagnostics—second part. Ital J Med 4:159–166CrossRef

18.

Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJ (2010) Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med 51:1937–1949CrossRefPubMed

19.

Treglia G, Mattoli MV, Leccisotti L, Ferraccioli G, Giordano A (2011) Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol 30:1265–1275CrossRefPubMed

20.

Tahara N, Imaizumi T, Virmani R, Narula J (2009) Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med 50:331–334CrossRefPubMed

21.

Israel O, Keidar Z (2011) PET/CT imaging in infectious conditions. Ann N Y Acad Sci 1228:150–166CrossRefPubMed

22.

Salvarani C, Pipitone N, Versari A, Vaglio A, Serafini D, Bajocchi G, Salvo D, Buzio C, Greco P, Boiardi L (2005) Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 53:298–303CrossRefPubMed

23.

Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, Salvarani C, Buzio C (2005) Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent “scar”? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol 23:231–234PubMed

24.

Nakajo M, Jinnouchi S, Tanabe H, Tateno R, Nakajo M (2007) 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis. J Comput Assist Tomogr 31:539–543CrossRefPubMed

25.

Young PM, Peterson JJ, Calamia KT (2008) Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases. Ann Nucl Med 22:87–92CrossRefPubMed

26.

Jansen I, Hendriksz TR, Han SH, Huiskes AW, van Bommel EF (2010) (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med 21:216–221CrossRefPubMed

27.

Piccoli GB, Consiglio V, Arena V, Pelosi E, Anastasios D, Ragni F, Fiori C, Cortese G, Deagostini MC, Porpiglia F, Scarpa RM (2010) Positron emission tomography as a tool for the ‘tailored’ management of retroperitoneal fibrosis: a nephro-urological experience. Nephrol Dial Transplant 25:2603–2610CrossRefPubMed

28.

Pipitone N, Versari A, Vaglio A, Salvarani C (2011) Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis. Clin Exp Rheumatol 29:S72–S78PubMed

29.

Ha YJ, Jung SJ, Lee KH, Lee SW, Lee SK, Park YB (2011) Retroperitoneal fibrosis in 27 Korean patients: single center experience. J Korean Med Sci 26:985–990CrossRefPubMed

30.

Bertagna F, Treglia G, Leccisotti L, Bosio G, Motta F, Giordano A, Giubbini R (2012) [(18)F] FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience. Jpn J Radiol 30:415–421CrossRefPubMed

31.

Guignard R, Simukoniene M, Garibotto V, Ratib O (2012) 18F-FDG PET/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis? Clin Nucl Med 37:453–459CrossRefPubMed

32.

Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, Arends B, Verzijlbergen FJ, Zijlstra J, Paans AM, Comans EF, Pruim J (2008) The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 35:2320–3233CrossRefPubMed

Titel: Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review
verfasst von: Giorgio Treglia
Maria Vittoria Mattoli
Francesco Bertagna
Raffaele Giubbini
Alessandro Giordano
Publikationsdatum: 01.03.2013
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 3/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-012-2576-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Bamboo nodes associated with mixed connective tissue disease as a cause of hoarseness

Psychosocial, educational, and somatic factors in chronic nonspecific low back pain

The relationship between body composition and bone mineral density in postmenopausal Turkish women

Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: What we still have to learn?

MicroRNA-155 as a therapeutic target for inflammatory diseases